AAAAAA
Results:
1-12
|
Results: 12
Authors:
ARAGA S
DOI S
ADACHI A
NAKASHIMA K
Citation: S. Araga et al., MONOCLONAL-ANTIBODY (MAB) TO A COMPLEMENTARY PEPTIDE FOR P2 PROTEIN RESIDUES-60-70 RECOGNIZES T-CELL RECEPTOR (TCR) SPECIFIC TO P2 PROTEIN-60-70 IN EXPERIMENTAL ALLERGIC NEURITIS (EAN), The FASEB journal, 12(5), 1998, pp. 6327-6327
Authors:
OKADA H
ARAGA S
TAKESHIMA T
NAKASHIMA K
Citation: H. Okada et al., PLASMA LACTIC-ACID AND PYRUVIC-ACID LEVELS IN MIGRAINE AND TENSION-TYPE HEADACHE, Headache, 38(1), 1998, pp. 39-42
Authors:
ARAGA S
DOI S
ADACHI A
NAKASHIMA K
Citation: S. Araga et al., T-CELL RECEPTOR V-BETA-8.3 DOMINATES THE P2 PROTEIN RESPONSE IN LEWISRAT EXPERIMENTAL ALLERGIC NEURITIS (EAN), Journal of allergy and clinical immunology, 99(1), 1997, pp. 1148-1148
Authors:
ARAGA S
DOI S
TAKAI H
KISHIMOTO M
ADACHI A
BLALOCK JE
NAKASHIMA K
Citation: S. Araga et al., MONOCLONAL-ANTIBODY (MAB) TO A COMPLEMENTARY PEPTIDE FOR TORPEDO ACETYLCHOLINE-RECEPTOR (ACHR) RESIDUES 100-116 RECOGNIZES T-CELL RECEPTORS(TCR) SPECIFIC TO ACHR-100-116 IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG), The FASEB journal, 10(6), 1996, pp. 1816-1816
Authors:
ARAGA S
GALIN FS
KISHIMOTO M
ADACHI A
BLALOCK JE
Citation: S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY A MONOCLONAL-ANTIBODY TO A COMPLEMENTARY PEPTIDE FOR THE MAIN IMMUNOGENIC REGIONOF THE ACETYLCHOLINE-RECEPTOR, The Journal of immunology, 157(1), 1996, pp. 386-392
Authors:
TAKAI H
ARAGA S
FUNAMOTO K
NAKAYASU H
TAKAHASHI K
Citation: H. Takai et al., THE 2-COLOR ANALYSIS OF THE T-LYMPHOCYTE SUBSETS IN EXPERIMENTAL ALLERGIC NEURITIS IN RATS, Internal medicine, 34(5), 1995, pp. 347-351
Authors:
ARAGA S
GALIN FS
KISHIMOTO M
ADACHI A
NAKAYASU H
BLALOCK JE
TAKAHASHI K
Citation: S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG) BY MONOCLONAL-ANTIBODY (MAB) TO A COMPLEMENTARY PEPTIDE FOR THE MAIN IMMUNOGENIC REGION (MIR) OF THE ACETYLCHOLINE-RECEPTOR (ACHR), The FASEB journal, 9(4), 1995, pp. 784-784
Authors:
ARAGA S
KISHIMOTO M
ADACHI A
NAKAYASU H
TAKENAKA T
TAKAHASHI K
Citation: S. Araga et al., THE CD5(+) B-CELLS AND MYASTHENIA-GRAVIS, Autoimmunity, 20(2), 1995, pp. 129-134
Authors:
ARAGA S
BLALOCK JE
Citation: S. Araga et Je. Blalock, PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS (EAMG) BY IMMUNIZATION WITH COMPLEMENTARY PEPTIDES TO T-CELL AND B-CELL EPITOPES, The FASEB journal, 8(5), 1994, pp. 10000745-10000745
Authors:
ARAGA S
LEBOEUF RD
BLALOCK JE
Citation: S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY MANIPULATION OF THE IMMUNE NETWORK WITH A COMPLEMENTARY PEPTIDE FOR THE ACETYLCHOLINE-RECEPTOR (VOL 90, PG 8747, 1993), Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1598-1598
Authors:
ARAGA S
LEBOEUF RD
BLALOCK JE
Citation: S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY MANIPULATION OF THE IMMUNE NETWORK WITH A COMPLEMENTARY PEPTIDE FOR THE ACETYLCHOLINE-RECEPTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 90(18), 1993, pp. 8747-8751
Authors:
ARAGA S
LEBOEUF RD
BLALOCK JE
Citation: S. Araga et al., PREVENTION OF EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS BY IMMUNIZATION WITH A COMPLEMENTARY PEPTIDE TO THE ACETYLCHOLINE-RECEPTOR, The Journal of immunology, 150(8), 1993, pp. 160-160
Risultati:
1-12
|